X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Transboundary and Emerging Diseases

期刊標題檢索 TRANSBOUND EMER 最新評論: Zheng Chunfu is Chinese, and the editor-in-chief is also Chinese. I ... (2024-04-05)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Transboundary and Emerging Diseases]您好,您是該頁面的第 67466 位訪客。

期刊簡介
期刊名稱Transboundary and Emerging Diseases Transboundary and Emerging Diseases
LetPub Score
8.4
50 ratings
Rate

Reputation
9.6

Influence
7.5

Speed
7.9

期刊簡稱TRANSBOUND EMERG DIS
ISSN1865-1674
E-ISSN1865-1682
h-index52
CiteScore
CiteScoreSJRSNIPCiteScore Rank
8.900.9211.020
Subject fieldQuartilesRankPercentile
Category: Veterinary
Subcategory: General Veterinary
Q13 / 194
Category: Veterinary
Subcategory: General Immunology and Microbiology
Q19 / 61

自引率 (2023-2024)2.90%自引率趨勢
掲載範囲
Transboundary and Emerging Diseases brings together in one place the latest research on infectious diseases considered to hold the greatest economic threat to animals and humans worldwide. The journal provides a venue for global research on their diagnosis, prevention and management, and for papers on public health, pathogenesis, epidemiology, statistical modeling, diagnostics, biosecurity issues, genomics, vaccine development and rapid communication of new outbreaks. Papers should include timely research approaches using state-of-the-art technologies. The editors encourage papers adopting a science-based approach on socio-economic and environmental factors influencing the management of the bio-security threat posed by these diseases, including risk analysis and disease spread modeling. Preference will be given to communications focusing on novel science-based approaches to controlling transboundary and emerging diseases. The following topics are generally considered out-of-scope, but decisions are made on a case-by-case basis (for example, studies on cryptic wildlife populations, and those on potential species extinctions):

Pathogen discovery: a common pathogen newly recognised in a specific country, or a new pathogen or genetic sequence for which there is little context about — or insights regarding — its emergence or spread.
Prevalence estimation surveys and risk factor studies based on survey (rather than longitudinal) methodology, except when such studies are unique. Surveys of knowledge, attitudes and practices are within scope.
Diagnostic test development if not accompanied by robust sensitivity and specificity estimation from field studies.
Studies focused only on laboratory methods in which relevance to disease emergence and spread is not obvious or can not be inferred (“pure research” type studies).
Narrative literature reviews which do not generate new knowledge. Systematic and scoping reviews, and meta-analyses are within scope.
官方網站http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1865-1682
在線稿件提交http://mc.manuscriptcentral.com/tbed
開放訪問No
出版商Wiley-Blackwell Publishing Ltd
主題領域农林科学
出版國/地區GERMANY
發行頻率月刊
創刊年2008
每年文章數175每年文章數趨勢
黃金OA百分比81.65%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
INFECTIOUS DISEASESSCIEQ245/132
VETERINARY SCIENCESSCIEQ111/167
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1865-1674%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 18-36 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【Transboundary and Emerging Diseases】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    LANCET INFECTIOUS DISEASESH-index: 201

    CiteScore: 60.90
    JOURNAL OF INFECTIONH-index: 90

    CiteScore: 45.90
    CLINICAL MICROBIOLOGY AND INFECTIONH-index: 131

    CiteScore: 25.30
    CLINICAL INFECTIOUS DISEASESH-index: 303

    CiteScore: 25.00
    EMERGING INFECTIOUS DISEASESH-index: 202

    CiteScore: 17.30
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICAH-index: 84

    CiteScore: 8.30
    INFECTIONH-index: 66

    CiteScore: 12.50
    JOURNAL OF INFECTIOUS DISEASESH-index: 231

    CiteScore: 13.50
    International Journal of Antimicrobial AgentsH-index: 111

    CiteScore: 21.60
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASESH-index: 73

    CiteScore: 18.90
    學科內最受檢索的期刊 頁面查看次數
    BMC INFECTIOUS DISEASES105471
    JOURNAL OF INFECTIOUS DISEASES100369
    JOURNAL OF INFECTION93417
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES83175
    CLINICAL INFECTIOUS DISEASES79875
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY68682
    International Journal of Antimicrobial Agents67797
    EMERGING INFECTIOUS DISEASES66367
    INFECTION AND IMMUNITY65757
    CLINICAL MICROBIOLOGY AND INFECTION60270
  •  

    Transboundary and Emerging Diseases Transboundary and Emerging Diseases
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Transboundary and Emerging Diseases] 的評論撰寫評論
作者: 晚上上线


領域: 医学
審稿時間: 3.0 month(s)
結果: 拒稿


撰寫評論

2024-04-05 21:28:35 評論於
Zheng Chunfu is Chinese, and the editor-in-chief is also Chinese. I complained to the editor-in-chief, but it has been close to half a year and I haven't received any response
(0) 讚! | 晚上上线

作者: 德云小生


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-24 17:34:28 評論於
Do not submit to the journals under Hindawi anymore, as they have been banned by the school. I submitted an article to this journal before, but it was later retracted! Is your editor Zheng Chunfu? It seems like he is from Canada, I have heard bad things about this person, he is an academic disgrace!
(0) 讚! | 德云小生

作者: 学术胖美云


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-14 11:03:59 評論於
1.14 PENDING APPROVAL
(0) 讚! | 学术胖美云

作者: 学术胖美云


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-12 18:17:54 評論於
1.12 under review
(0) 讚! | 学术胖美云

作者: 晚上上线


領域: 医学
審稿時間: 3.0 month(s)
結果: 拒稿


撰寫評論

2024-01-09 11:06:17 評論於
Because of the practice of not getting approval from him, giving him a thank-you fee. Complaining to the magazine, the magazine has a default attitude. Especially Chinese editor Zheng Chunfu
(15) 讚! | 晚上上线

作者: 晚上上线


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-31 10:57:02 評論於
Do you feel happy when your submission is rejected just because you don't agree with the editor's threats?
(0) 讚! | 晚上上线

作者: 晚上上线


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-31 10:54:23 評論於
The editor sent an email asking for recommended reviewers, stating that a fee is required for inviting foreign reviewers. Is this journal really so dark now?
(0) 讚! | 晚上上线

作者: pubpubCNS


領域: 农林科学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-28 22:35:20 評論於
Has your article been accepted?
(0) 讚! | pubpubCNS

作者: pubpubCNS


領域: 农林科学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-28 19:19:15 評論於
I was just assigned as the deputy editor a few days ago... How do I know if it needs to be sent for external review?
(0) 讚! | pubpubCNS

作者: 晚上上线


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-03 16:11:24 評論於
Where can I see the assignments for the assistant editors?
(0) 讚! | 晚上上线

作者: 德云小生


領域: 农林科学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-23 15:02:29 評論於
Submission made on 1006, deputy editor assigned a few days ago, but as of today 1023, academic editor has not been assigned yet!
Before, Chinese authors were very eager to submit to our journal, now the number of submissions from Chinese authors has decreased in Zone 2. Why are most of the submitted articles on topics like epidemiology, and very few on mechanisms?
(0) 讚! | 德云小生

作者: zqx


領域: 农林科学
審稿時間: 4.0 month(s)
結果: 修改後接受


撰寫評論

2023-10-23 10:57:17 評論於
The submission link has been transferred to Hindawi, and there are Chinese submissions for the latest articles in 2023
(0) 讚! | zqx

作者: 德云小生


領域: 农林科学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-09 01:15:31 評論於
The submission system is the simplest I have encountered, only requiring the submission of a manuscript. At the same time, it is also the most rubbish! The design is too simple, there is no way to preview, and every time you log in, there will be unsent drafts!
(0) 讚! | 德云小生

作者: 德云小生


領域: 农林科学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-05 13:02:35 評論於
This journal is also in the field of agriculture and forestry, and the impact factor is also acceptable. Why are Chinese people not submitting articles recently? What is the reason?
(43) 讚! | 德云小生

作者: Fei1990


領域: 农林科学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2021-08-14 15:56:03 評論於
The editors are very nice! They are very patient. The reviewers are professional and responsible. The magazine processes manuscripts efficiently and quickly. If the article is well-written, it can be published within less than two months from submission. It is also a first-tier journal, a very good one!
(0) 讚! | Fei1990

作者: Deng Qiaomu


領域: 农林科学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2021-01-22 23:10:51 評論於
Last August, I submitted to VIRUS EVOL, but it was rejected after the first review. On October 15th, I submitted to TRANSBOUND EMERG DIS, and it went through minor revisions on December 10th. On the 19th, it was sent back for further revisions, and on the 20th, it was accepted. I feel extremely lucky!
(31) 讚! | Deng Qiaomu

作者: CNS


領域: 生命科学
審稿時間: 12.0 month(s)
結果: 拒稿


撰寫評論

2018-07-11 10:37:55 評論於
This journal has high standards for content and language of paper. My paper was first rejected for language issues. I revised the language and re-submitted, but the paper was rejected because the content was not sufficiently novel. I didn’t think the paper is that bad; so sad...

(0) 讚! | CNS

作者: 匿名


領域: 1.854
審稿時間: 0.0 month(s)
結果:


撰寫評論

2011-01-28 16:37:00 評論於
 (0) 讚! | 匿名  

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Transboundary and Emerging Diseases] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*